Antiproliferative Properties of the Serotonin Receptor Antagonist Ondansetron Correlate with Increased Nitric Oxides Release and Inducible Nitric Oxide Synthase Activity in the Acute Lymphoblastic Leukemia Cell Line REH

A recent report from our group described that the (serotonin receptor-3)-antagonist ondansetron exhibits antiproliferative effects in the B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cell line REH. Furthermore, after each application of ondansetron to cultured REH cells, significant increases (+23%) in the concentration of nitric oxides (NO) were observed in the cell supernatants after 72 hours incubation in standard conditions, and this effect was found to correlate with the described antiproliferative activity. This feature was further confirmed by using mRNA dot blot hybridizations with a specific gene probe for the inducible NO-synthase (iNOS), yielding significant increases (+100%) of iNOS mRNA, which were found to widely correlate with the detected increases of NO release, and also with the previously described antiproliferative effects. The presented results are the first report on high specific pro-inflammatory features of a (serotonin receptor 3)-antagonist in a BCP-ALL cell line, which are associated with previously described antiproliferative properties.

[1]  J. Kaur,et al.  A novel parthenin analog exhibits anti-cancer activity: activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells. , 2011, Chemico-biological interactions.

[2]  K. Seeger,et al.  Antiproliferative effect of the serotonin receptor antagonist ondansetron in the acute lymphoblastic leukemia cell line REH , 2011, Acta oncologica.

[3]  S. Fucharoen,et al.  Nitric oxide and caspase 3 mediated cytokine induced apoptosis in acute leukemia. , 2011, Asian Pacific journal of allergy and immunology.

[4]  K. Mousavizadeh,et al.  Anti‐inflammatory effects of 5‐HT3 receptor antagonist, tropisetron on experimental colitis in rats , 2009, European journal of clinical investigation.

[5]  H. Chakrapani,et al.  Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound. , 2008, Bioorganic & medicinal chemistry.

[6]  S. Tsuzuki,et al.  Genetic abnormalities involved in t(12;21) TEL–AML1 acute lymphoblastic leukemia: Analysis by means of array‐based comparative genomic hybridization , 2007, Cancer science.

[7]  T. Ng,et al.  Isolation and characterization of a glucose/mannose-specific lectin with stimulatory effect on nitric oxide production by macrophages from the emperor banana. , 2006, The international journal of biochemistry & cell biology.

[8]  B. Shashi,et al.  A novel lignan composition from Cedrus deodara induces apoptosis and early nitric oxide generation in human leukemia Molt-4 and HL-60 cells. , 2006, Nitric oxide : biology and chemistry.

[9]  J. Reiffers,et al.  Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron , 2002, Leukemia.

[10]  K. Mašek,et al.  Is nitric oxide involved in 5-HT3 receptor-mediated neurogenic relaxation of guinea pig proximal colon? , 1998, Japanese journal of pharmacology.

[11]  H. Drexler,et al.  Establishment and characterization of human B cell precursor-leukemia cell lines. , 1998, Leukemia research.

[12]  M. Holdsworth,et al.  Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron , 1998, Supportive Care in Cancer.

[13]  P. Kremsner,et al.  Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether. , 1996, The Journal of antimicrobial chemotherapy.

[14]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.